AdaptHealth Sells Diabetes Business for $235M, Cuts Guidance Amid Margin Pressures
Event summary
- Completed first full quarter under exclusive capitated agreement with a large national integrated delivery network.
- Signed new capitated agreement with Humana OneHome, transitioning ~478K members in South Florida and Texas.
- Agreed to sell Diabetes Health business for $235M in cash, marking significant portfolio focus shift.
- Reported 15.9% organic revenue growth but lowered full-year EBITDA guidance by ~$200M due to margin pressures.
- Launched AI-powered mask-fitting tool and grew myAPP users by 56% YoY.
The big picture
AdaptHealth's strategic pivot toward Sleep Health, Respiratory Health, and Wellness-at-Home businesses reflects broader industry consolidation trends. The $235M divestiture underscores a push for operational efficiency amid margin pressures from large-scale capitated agreements. With revenue growth outpacing EBITDA gains, the company faces execution challenges in balancing scale with profitability.
What we're watching
- Portfolio Optimization
- Whether the $235M Diabetes Health divestiture will successfully streamline operations and improve profitability.
- Margin Recovery
- How AdaptHealth addresses cost pressures from rapid growth and capitated contract complexities.
- Digital Engagement
- The pace at which AI-powered tools like the mask-fitting feature drive patient adoption and operational efficiency.
Related topics